大麻与内镜检查:大麻使用对镇静的影响
这项单机构前瞻性研究纳入976例门诊内镜检查患者,21.5%承认使用大麻。大麻使用与更高镇静需求相关,多因素分析显示大麻使用是MAC病例中高丙泊酚用量的独立预测因素(OR 1.77,95%CI 1.00-3.12),也是高咪达唑仑用量(OR 1.57,95%CI 1.02-2.42)和高芬太尼用量(OR 1.54,95%CI 0.98-2.38)的独立预测因素,但芬太尼组未达统计学显著。
要点
- 大麻使用者内镜检查时镇静需求更高。
- 大麻使用是MAC病例中高丙泊酚用量的独立预测因素。
- 确定内镜镇静方法时应考虑患者大麻使用史。
核心结论
- 大麻使用与内镜检查时显著更高的镇静用量及显著更高的辅助镇静剂使用相关。
- 确定内镜检查镇静方法时应考虑患者的大麻使用史。
研究设计与样本
- 单机构前瞻性研究,纳入在俄克拉何马城退伍军人事务医疗中心接受门诊内镜检查(包括监测麻醉护理[MAC]和中度镇静)的患者,共分析976例。
- 大麻使用情况通过自愿、去标识化的内镜检查前问卷评估。
主要发现
- 976例患者中21.5%(210/976)承认使用大麻。
- 大麻使用者更年轻(P=.0002)、更瘦(P<.0001),糖尿病(P=.002)、阻塞性睡眠呼吸暂停(P=.0002)和高血压(P=.04)的可能性更低,吸烟(P<.0001)和电子烟使用(P<.0001)的可能性更高。
- 大麻使用与更高镇静需求相关:芬太尼(P=.003)、咪达唑仑(P=.05)、丙泊酚(P=.02),以及中度镇静中更高使用辅助镇静剂苯海拉明(P=.0003)。
- 多因素分析显示,大麻使用是MAC病例中高丙泊酚用量的独立预测因素(OR 1.77;95%CI 1.00-3.12)。
- 大麻使用是高咪达唑仑用量(OR 1.57;95%CI 1.02-2.42)和高芬太尼用量(OR 1.54;95%CI 0.98-2.38)的独立预测因素,但芬太尼组未达统计学显著。
临床怎么用
- 原文结论指出,确定内镜检查镇静方法时应考虑患者的大麻使用史。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Marijuana usage has increased significantly as it has become more readily available and legal, either recreationally or medicinally, in many states. It has been postulated that marijuana usage increases the amount of sedation required for procedures. However, there are minimal data defining this relationship. We aimed to establish the relationship between marijuana usage and the amount of sedation used during endoscopy. METHODS: This was a single-institution prospective study of patients undergoing outpatient endoscopy (both monitored anesthesia care [MAC] and moderate sedation) at the Oklahoma City Veterans Affairs Medical Center. Marijuana usage was assessed by a voluntary de-identified pre-endoscopy survey. Information regarding sedation used, endoscopy outcomes, demographics, comorbidities, medical history, and medications used was extracted from the medical record. A univariate and stratified analysis of alcohol usage was performed. A P value of <.05 was considered to be significant. RESULTS: A total of 976 patients were analyzed; 21.5% of them endorsed marijuana usage (210/976). Marijuana users were found to be younger (P = .0002), leaner (P < .0001), and less likely to have diabetes (P = .002), obstructive sleep apnea (P = .0002), and hypertension (P = .04). They were also more likely to smoke (P < .0001) and vape (P < .0001). Marijuana usage was associated with a higher requirement of sedation (fentanyl [P = .003], midazolam [P = .05], propofol [P = .02]) and higher use of adjunct sedation (diphenhydramine in moderate sedation [P = .0003]). Further multivariate analyses were performed to control for possible confounders. Marijuana usage was still deemed to be an independent predictor for high propofol use among MAC cases (odds ratio [OR], 1.77; 95% confidence interval [CI], 1.00-3.12). Likewise, marijuana usage was found to be an independent predictor for high midazolam use (OR, 1.57; 95% CI, 1.02-2.42) and high fentanyl use (OR, 1.54; 95% CI, 0.98-2.38), but failed to reach statistical significance in the fentanyl group. CONCLUSIONS: Marijuana use is associated with a significantly higher amount of sedation along with a significantly higher usage of other adjunct sedatives. A patient's marijuana history should be considered when determining the methods of sedation to be used for endoscopy.
引用
- Kosirog J, Bouvette C, Pannu J, et al. Marijuana and endoscopy: the effects of marijuana on sedation. Gastrointest Endosc. 2024. PMID: 38215858. doi:10.1016/j.gie.2024.01.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。